The HDAC inhibitor LBH589 enhances the antimyeloma effects of the IGF-1RTK inhibitor picropodophyllin. (Q39384823)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

The HDAC inhibitor LBH589 enhances the antimyeloma effects of the IGF-1RTK inhibitor picropodophyllin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

ChEBI release 2020-05-28

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Eline Menu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Miguel Lemaire

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Charlotte Fristedt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Els Van Valckenborgh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Elke De Bruyne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Anders Österborg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Peter Atadja

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Olle Larsson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Magnus Axelson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Ben Van Camp

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Helena Jernberg-Wiklund

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Karin Vanderkerken

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

5 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

2230-2239

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

10.1158/1078-0432.CCR-11-1764

25 January 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392915%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference